CPEX Pharmaceuticals Inc said it appointed Lance Berman as its chief medical officer, effective February 2, 2009. Berman succeeds Robert Stote, who has been serving as the chief medical officer of CPEX since its spin-off from Bentley Pharmaceuticals, Inc. in June of 2008. Stote, who is retiring, will continue as a clinical consultant for CPEX.

Berman, who has extensive experience with large pharmaceutical companies in the areas of drug development, licensing and new product commercialization across a broad range of therapeutic areas, was most recently senior medical director and global medical team leader at Pfizer.